233 related articles for article (PubMed ID: 17560607)
1. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1.
Zebisch M; Krauss M; Schäfer P; Sträter N
J Mol Biol; 2012 Jan; 415(2):288-306. PubMed ID: 22100451
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties.
Haller CA; Cui W; Wen J; Robson SC; Chaikof EL
J Vasc Surg; 2006 Apr; 43(4):816-23. PubMed ID: 16616242
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
5. Red Wine Inhibits Aggregation and Increases ATP-diphosphohydrolase (CD39) Activity of Rat Platelets in Vitro.
Caiazzo E; Tedesco I; Spagnuolo C; Russo GL; Ialenti A; Cicala C
Nat Prod Commun; 2016 Jun; 11(6):771-4. PubMed ID: 27534113
[TBL] [Abstract][Full Text] [Related]
6. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
7. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
8. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
9. A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila.
Sansom FM; Newton HJ; Crikis S; Cianciotto NP; Cowan PJ; d'Apice AJ; Hartland EL
Cell Microbiol; 2007 Aug; 9(8):1922-35. PubMed ID: 17388784
[TBL] [Abstract][Full Text] [Related]
10. Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.
Leal DB; Streher CA; Neu TN; Bittencourt FP; Leal CA; da Silva JE; Morsch VM; Schetinger MR
Biochim Biophys Acta; 2005 Jan; 1721(1-3):9-15. PubMed ID: 15652174
[TBL] [Abstract][Full Text] [Related]
11. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
[TBL] [Abstract][Full Text] [Related]
12. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection.
Marcus AJ; Broekman MJ; Drosopoulos JH; Olson KE; Islam N; Pinsky DJ; Levi R
Semin Thromb Hemost; 2005 Apr; 31(2):234-46. PubMed ID: 15852226
[TBL] [Abstract][Full Text] [Related]
13. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
Gayle RB; Maliszewski CR; Gimpel SD; Schoenborn MA; Caspary RG; Richards C; Brasel K; Price V; Drosopoulos JH; Islam N; Alyonycheva TN; Broekman MJ; Marcus AJ
J Clin Invest; 1998 May; 101(9):1851-9. PubMed ID: 9576748
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras.
Grinthal A; Guidotti G
Biochemistry; 2002 Feb; 41(6):1947-56. PubMed ID: 11827541
[TBL] [Abstract][Full Text] [Related]
16. Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma.
Jiang ZG; Wu Y; Csizmadia E; Feldbrügge L; Enjyoji K; Tigges J; Toxavidis V; Stephan H; Müller CE; McKnight CJ; Moss A; Robson SC
Purinergic Signal; 2014 Dec; 10(4):611-8. PubMed ID: 25165006
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39.
Papanikolaou A; Papafotika A; Murphy C; Papamarcaki T; Tsolas O; Drab M; Kurzchalia TV; Kasper M; Christoforidis S
J Biol Chem; 2005 Jul; 280(28):26406-14. PubMed ID: 15890655
[TBL] [Abstract][Full Text] [Related]
18. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis.
Glenn JR; White AE; Johnson AJ; Fox SC; Myers B; Heptinstall S
Platelets; 2008 Feb; 19(1):59-69. PubMed ID: 18231939
[TBL] [Abstract][Full Text] [Related]
19. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Alyonycheva TN; Safier LB; Hajjar KA; Posnett DN; Schoenborn MA; Schooley KA; Gayle RB; Maliszewski CR
J Clin Invest; 1997 Mar; 99(6):1351-60. PubMed ID: 9077545
[TBL] [Abstract][Full Text] [Related]
20. Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1.
McGuinness AN; Tahir A; Sutton NR; Marquis AD
Purinergic Signal; 2024 Jun; 20(3):257-271. PubMed ID: 37165287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
